EID Parry reported a significant increase in Q4 EBITDA, reaching ₹6.1 billion, up from ₹5.3 billion the previous year. Despite this growth, their EBITDA margin slightly dipped to 7.76% compared to the previous year's 7.78%.

Blue Jet Healthcare has given the green light for an equity fundraise worth up to ₹1,000 crores. This move signals the company's intent to bolster its financial resources.

HealthCare Global Enterprises announces the appointment of Sanjeev Kumar as its new Chief Financial Officer, effective from May 25, 2026. The previous Interim CFO, Dr. Manish Mattoo, has stepped down. The board approved the decision on May 19, 2026.

Hitachi Energy, Suzlon Energy, and several other companies like Rail Vikas Nigam, Sundaram Finance, CONCOR, NBCC, Pine Labs, and Poly Medicure are all set to release their Q4 financial results today. Investors will be eagerly awaiting the updates on these firms' performance for the quarter ending in December 2021.

Angel One and 360 One Wam witnessed impressive 250% Q4 profit growth, leading to a surge in their stock prices. Conversely, shares of investment platform Groww experienced an 11.6% dip during the same period.

Anand Rathi's Jigar Patel suggests investors consider Dixon Tech, Aarti Industries, and Ramco Cements for short-term investment opportunities. The Nifty 50 index is currently holding steady within a range, with notable resistance at 24,200 and support at 23,300. Bank Nifty shows potential for breaking through the 54,500 level.

Seven companies, including Abbott India, Torrent Pharma, and Sun Pharma, have announced their dividend record dates. This means shareholders of these companies will receive their dividends soon, as stated in the companies' respective announcements.

Jupiter Wagons' subsidiary secures new orders worth ₹150 crore from renewable energy developers for battery storage systems, with a goal to reach ₹1,000 crore in total orders by fiscal year 2030. The company aims to increase its order book to ₹200 crore by fiscal year 2027 and ₹500 crore by fiscal year 2028.

HPCL and BPCL shares saw gains today as the Nifty Oil & Gas index climbed 1.6%, following fuel price increases of ₹7.5 per liter. The higher prices could bolster profits for oil marketing companies, but may contribute to escalating inflation concerns.

Narayana Hrudayalaya's Q4 revenue surged by 76% to ₹25,938 million due to robust growth across various locations. Despite this, the consolidated profit after tax increased by only 16%, reaching ₹2,283 million. The company's shares closed at ₹1,854.35, marking a slight drop from their previous trading price of ₹1,928.70.

JK Cement's Q4 earnings saw a decrease in EBITDA to ₹6.7 billion, marking a year-on-year drop from ₹7.4 billion. The margin narrowed significantly, falling from 21.8% to 18.2%. This suggests a less profitable quarter for the company compared to last year.

Pudumjee Paper's Q4 earnings show a significant increase, with EBITDA jumping by 36% year-on-year to reach INR 395 million. The improved performance is also reflected in the expanded margin, now at 19.7%, up from 15.3% in the previous year.

Despite Gokaldas Exports' revenue growth in Q4, the net profit dropped by 32% year-on-year to ₹360 million, indicating operational challenges despite increased sales.

IOL Chemicals aims to achieve mid to high-teen revenue growth by investing ₹1,200-1,400 crore in a multi-year expansion plan for their pharmaceutical division. The phased expansion over 4-5 years will fuel their strategic growth objectives within the sector.

NGL Fine-Chem's Q4 revenue increased significantly by 56% year over year to INR 145 crore, accompanied by a net profit of INR 11 crore. The board suggested a dividend of INR 1.75, with the stock currently trading at INR 2,505 and key financial metrics such as P/E ratio at 36.8, ROCE at 16.6%, and ROE at 14.9%.

Fortis Healthcare has announced a significant rise in its Q4 EBITDA, reaching ₹5.3B compared to ₹4.4B the previous year. The improvement also extended to the EBITDA margin, which increased from 21.9% YoY to 22.5%.

EIH Hotels has disclosed their Q4 financial outcomes, highlighting significant figures. Stay tuned for more details about their performance in the final quarter of 2021.

Manali Petrochemicals significantly boosted its Q4 profit by 2.6 times, reaching ₹29 crore compared to the previous year. This growth was accompanied by a 23% increase in revenue to ₹293 crore in the same quarter of FY26.

Morgan Stanley anticipates a significant 37% increase in Maruti Suzuki's share price following its price hike, thanks to improved margins predicted to stabilize in Q1 of the fiscal year 2026-27, enhancing the automaker's stock prospects.

Sansera Engineering has announced a capital expenditure (CapEx) of INR 5,097 million for FY27, maintaining the level from the previous year. The company aims to use these funds to strengthen its Internal Combustion Engine capabilities and establish new facilities for Advanced Driver Systems (ADS).

Vedanta's Talwandi Sabo Power subsidiary was ordered to pay a fine of INR 127 crore by the Supreme Court due to a grid code violation in 2017, causing a 1.2% dip in Vedanta's share price on BSE, closing at INR 329.75 for the day.

ITC's Q4 results have outshone expectations, boasting an impressive EBITDA margin of 40%, marking a significant achievement for the company.

The stock market shows a positive start with GIFT Nifty, driven by significant earnings, deals, and actions in key players like Paytm, Maruti Suzuki, Nykaa, and GAIL. Notably, Paytm's block deal is priced at Rs 1,120.65/share, while Maruti announces a price hike of up to Rs 30,000 per vehicle. Impressively, Nykaa reports a profit growth of 286%.

Jubilant Pharmova anticipates an increase in earnings before interest, tax, depreciation, and amortization (EBITDA) margins from the second half of their fiscal year 2027, due to Montreal's production stabilizing. This improvement is intended to offset higher depreciation costs and foster stronger net profit growth.

Laxmi Dental experienced a significant increase in its Q4 net profit, jumping by 135% year-on-year to reach ₹101 million. The revenue also saw an uptick, reaching ₹722 million compared to the previous year.

In the fiscal year 2026, Le Travenues Technology Ltd (ixigo) reported a significant 34% increase in revenue, reaching INR 1,228 crores. The company aims for further growth by leveraging artificial intelligence technologies.

Bernstein has recommended investing in Zydus, Lupin, and Sun Pharma, predicting a potential $75 billion growth in India's biopharmaceutical sector over the next decade. The firm believes that innovation, AI integration, and focus on niche therapies could propel this growth, with Zydus being their top choice. Biocon and Mankind Pharma were rated as less promising investments.

DOMS Industries Ltd faces a significant demand of approximately 46.8 lakhs from the customs authority due to alleged misclassification of goods. The demand includes a GST amount of around 13.4 lakhs, a penalty of equal amount, and a redemption fine worth 20 lakhs.

Brand Concepts Ltd announces the transfer of 13.01% shares (16,24,220 shares) from Pradeep Maheshwari to his son Prateek Maheshwari, according to an off-market transaction declared as a gift. This move is compliant with SEBI SAST Regulation 10(1)(a)(i) exemption provisions.

IRB Infra aims to expand its assets to a significant ₹1.4 trillion by 2029, with the goal of operating completely free of debt by the same year.

"NNM Securities offloaded approximately 390,000 shares of Magnum Ventures, with an average selling price of Rs 19.9 each."

Experts advise investors to maintain their positions in Apollo Tyres and Siemens, while considering purchases of JSW Steel, Hero MotoCorp, and NMDC. Vodafone Idea requires careful profit booking due to ongoing challenges like the impact of crude prices on tyre makers and debt issues. However, JSW Steel and NMDC are seen with upside potential, while Siemens shows resilience in the market.

The Nifty Pharma index has significantly outperformed the broader market, increasing by 11% over the past month while the Nifty 50 experienced a decline of 3.6%. Notable standouts in this sector include Gland Pharma with a impressive 27% gain, Laurus Labs at 23%, and Biocon showing a 21% rise.

Minda Corp reported a 19% increase in Q2 revenue and a 14% rise in profits, signaling strong financial growth for the company, potentially impacting its stock value.

HSBC maintains its neutral stance on PI Industries, setting a price target at ₹3000, despite weak Q4FY26 results attributed to challenges in the agribusiness sector and rising overhead costs. The bank's assessment suggests earnings may be impacted by uncertainties in the core business and slow growth of new initiatives.

HCL Infosystems reported a significant decrease in revenue for FY26, standing at INR 2,160.9L compared to the previous year's INR 2,461.3L. The company also posted an increased loss before tax for FY26, totaling INR 3,291.5L. In Q4 alone, the pre-tax loss amounted to INR 1,315.7L, with a substantial portion of expenses, approximately INR 1,712.8L, attributed to legal and arbitration efforts.

KDDL Limited has announced a final dividend of ₹8 per share for the fiscal year 2025-2026, following the approval of their audited financials. The audit report was clean, indicating no significant concerns or discrepancies, and they will not be classified as a Large Corporate for this fiscal year.

Shivalik Bimetal's shares saw an uptick, reaching ₹640 on May 20, 2026, marking a continuation of active trading from the previous day at ₹638.55 (May 19, 2026). Data from Tickertape confirms this momentum.

Refex Industries has bagged a significant ₹20.27 crore logistics contract from a prominent Miniratna firm, marking a promising development for the company. The project is slated for completion in approximately six months.

BPCL's Q4 earnings fell short of forecasts, yet its operational results outperformed expectations. Despite the profit miss, the company demonstrated strong operational efficiency in the fourth quarter.